BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17177831)

  • 1. The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.
    Desmetz C; Lin YL; Mettling C; Portalès P; Rabesandratana H; Clot J; Corbeau P
    Immunology; 2006 Dec; 119(4):551-61. PubMed ID: 17177831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.
    Desmetz C; Lin YL; Mettling C; Portalès P; Noël D; Clot J; Jorgensen C; Corbeau P
    Clin Immunol; 2007 May; 123(2):148-54. PubMed ID: 17363330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.
    Kang SG; Piniecki RJ; Hogenesch H; Lim HW; Wiebke E; Braun SE; Matsumoto S; Kim CH
    Gastroenterology; 2007 Mar; 132(3):966-81. PubMed ID: 17324406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
    Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
    AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
    Ubogu EE; Callahan MK; Tucky BH; Ransohoff RM
    J Neuroimmunol; 2006 Oct; 179(1-2):132-44. PubMed ID: 16857269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
    J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
    Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV
    J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemoattraction of lymphocytes by rheumatoid arthritis - synovial fluid is not dependent on the chemokine receptor CCR5.
    Santiago B; Galindo M; Rivero M; Brehmer MT; Mateo I; Pablos JL
    Rheumatol Int; 2002 Jul; 22(3):107-11. PubMed ID: 12111085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling.
    Rabin RL; Park MK; Liao F; Swofford R; Stephany D; Farber JM
    J Immunol; 1999 Apr; 162(7):3840-50. PubMed ID: 10201901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tick saliva inhibits the chemotactic function of MIP-1alpha and selectively impairs chemotaxis of immature dendritic cells by down-regulating cell-surface CCR5.
    Oliveira CJ; Cavassani KA; Moré DD; Garlet GP; Aliberti JC; Silva JS; Ferreira BR
    Int J Parasitol; 2008 May; 38(6):705-16. PubMed ID: 18023445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
    Vaday GG; Peehl DM; Kadam PA; Lawrence DM
    Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel CCR5-specific pharmacodynamic assay in whole blood using phosphoflow cytometry highlights different ligand-dependent responses but similar properties of antagonists in CD8+ and CD4+ T lymphocytes.
    Dahl ME; Berson A; Lora J; Fuentes M
    J Pharmacol Exp Ther; 2008 Dec; 327(3):926-33. PubMed ID: 18753410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant responsiveness to RANTES in synovial fluid T cells from patients with rheumatoid arthritis.
    Hisakawa N; Tanaka H; Hosono O; Nishijima R; Ohashi Y; Saito S; Nishiya K; Hashimoto K; Morimoto C
    J Rheumatol; 2002 Jun; 29(6):1124-34. PubMed ID: 12064824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation.
    Inston N; Drayson M; Ready A; Cockwell P
    Exp Clin Transplant; 2007 Dec; 5(2):638-42. PubMed ID: 18194114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.
    Zaunders JJ; Moutouh-de Parseval L; Kitada S; Reed JC; Rought S; Genini D; Leoni L; Kelleher A; Cooper DA; Smith DE; Grey P; Estaquier J; Little S; Richman DD; Corbeil J
    J Infect Dis; 2003 Jun; 187(11):1735-47. PubMed ID: 12751031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis.
    Mack M; Brühl H; Gruber R; Jaeger C; Cihak J; Eiter V; Plachý J; Stangassinger M; Uhlig K; Schattenkirchner M; Schlöndorff D
    Arthritis Rheum; 1999 May; 42(5):981-8. PubMed ID: 10323454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.